Breast imaging is used to obtain high-resolution visualization of breast tissues and associated diseases. Breast cancer is the leading cause of the breast disease that requires immediate screening, which in turn is expected to boost the growth of the breast imaging market.
Breast cancer can occur both in men and women, though it is majorly reported in females. The most common breast imaging tests used to determine breast cancer and related disease are ultrasound, mammography, nuclear imaging MRI, and thermography.
The growing incidences of breast cancer primarily drive the global market for the Breast Imaging Market. For instance, according to the American Institute Of Cancer Research (AICR), breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. However, the high cost of breast imaging systems, unfavorable reimbursement scenario, side-effects of radiation exposure may hinder the market growth of breast imaging.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
